The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 26, 2021

Filed:

Jul. 06, 2016
Applicant:

Max-planck-gesellschaft Zur Foerderung Der Wissenschaften E. V., Munich, DE;

Inventors:

Joachim P. Spatz, Stuttgart, DE;

Fania Geiger, Leonberg, DE;

Michael Thaller, Stuttgart, DE;

Christian Lingenfelder, Ulm, DE;

Heike Boehm, Weinheim, DE;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61L 31/10 (2006.01); A61F 9/007 (2006.01); C08B 37/08 (2006.01); C08J 3/075 (2006.01); C08J 3/24 (2006.01); C09D 105/08 (2006.01); C08L 5/08 (2006.01); A61L 27/34 (2006.01); A61L 27/20 (2006.01); A61L 27/06 (2006.01); A61L 31/02 (2006.01); A61L 31/04 (2006.01); A61L 31/14 (2006.01);
U.S. Cl.
CPC ...
A61L 31/10 (2013.01); A61F 9/00781 (2013.01); A61L 27/06 (2013.01); A61L 27/20 (2013.01); A61L 27/34 (2013.01); A61L 31/022 (2013.01); A61L 31/026 (2013.01); A61L 31/04 (2013.01); A61L 31/145 (2013.01); C08B 37/0072 (2013.01); C08J 3/075 (2013.01); C08J 3/24 (2013.01); C08L 5/08 (2013.01); C09D 105/08 (2013.01); A61F 2240/001 (2013.01); A61L 2430/16 (2013.01); C08J 2305/08 (2013.01);
Abstract

The present invention relates to an ocular device for regulating intraocular fluid pressure comprising or consisting of a tubular body wherein the inner surface of the tubular body or the inner and outer surface is/are coated with covalently immobilized hyaluronic acid (HA). In more specific embodiments, the tubular body comprises or consists of a biocompatible material selected from the group comprising a biocompatible metal such as titanium, ceramics, glass, polymers and composites thereof, and the immobilized hyaluronic acid molecules are linked with further HA molecules to form a HA hydrogel. The ocular device is a stent free from mechanical valves or other mechanical means for actively regulating the flow of intraocular fluid.


Find Patent Forward Citations

Loading…